world1 outlet covering thisCalibrating

Legend Biotech stock falls as CEO Ying Huang steps down

First publishedJul 27, 13:25 UTC
Last updatedJul 27, 16:28 UTC · 9m ago
11 outletInvesting.com · Stock Market
1 outlets over time — hover a bar for its window & outletslast updated
Legend Biotech stock falls as CEO Ying Huang steps down
● Story signals

How strong is this topic?

5.9/10Significanceimpact & urgency
6.0/10Source trustoutlet authority
1Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Investing.com -- Legend Biotech Corporation (NASDAQ:LEGN) shares fell 5.7% in premarket trading Monday following the announcement that CEO Ying Huang has stepped down from his position and from the Board of Directors. The company named Alan Bash, current President of the CARVYKTI Business Unit, as Interim Chief Executive Officer effective July 24.

Reported by 1 outlet Investing.com · Stock Market. See all sources ↓

Investing.com -- Legend Biotech Corporation (NASDAQ:LEGN) shares fell 5.7% in premarket trading Monday following the announcement that CEO Ying Huang has stepped down from his position and from the Board of Directors. The company named Alan Bash, current President of the CARVYKTI Business Unit, as Interim Chief Executive Officer effective July 24. Huang will remain as an advisor through August to support the transition, while the Board has initiated a search process to identify a permanent successor. Huang had led Legend Biotech for seven years, during which the company advanced from a pioneering cell therapy company into a commercial-stage organization.

Read the full report at Investing.com · Stock Market

Why it matters

A world story we're tracking; its significance and source trust firm up as more outlets confirm it.

In brief
What's the story?
Investing.com -- Legend Biotech Corporation (NASDAQ:LEGN) shares fell 5.7% in premarket trading Monday following the announcement that CEO Ying Huang has stepped down from his position and from the Board of Directors. The company named Alan Bash, current President of the CARVYKTI Business Unit, as Interim Chief Executive Officer effective July 24.
How widely is it covered?
1 outlet, average source rating 6.0/10.
When was it last updated?
9m ago.
Different angles across outlets
Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

  • Coverage card1 outlet
    1Coverage
    Scouting report

    Legend Biotech stock falls as CEO Ying Huang steps down

    Sources1
    TypeCoverage
    Investing.com · Stock Market
Related in the knowledge graph
Sources (1)
Avg source rating 6.0/10
Processing cluster
A1A2A3B1B2B3
Share this article
Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)